 |
|
Personalized medicine helps cancer patients survive
April 20, 2009Cancer patients can survive longer under treatments based on their individual genetic profiles, according to a nationwide study released jointly today by Phoenix-area healthcare organizations.
The study shows that molecular profiling of patients can identify specific treatments for individuals, helping keep their cancer in check for significantly longer periods, and in some cases even shrinking tumors.
Study results were released today at the 100th annual meeting of the American Association for Cancer Research in Denver by Dr. Daniel Von Hoff, Physician-In-Chief of the Phoenix-based Translational Genomics Research Institute (TGen), and the study's Principal Investigator.
The study included 66 patients at nine centers across the United States, including Scottsdale Heathcare. Dr. Von Hoff also is the Chief Scientific Officer of TGen Clinical Research Services (TCRS) at Scottsdale Healthcare, a partnership between TGen and Scottsdale Healthcare that is administered by the Scottsdale Clinical Research Institute (SCRI) at Scottsdale Healthcare.
All of the patients had previously experienced growth of their tumors while undergoing as many as two to six prior cancer treatments, including conventional chemotherapy.
However, after molecular profiling identified precise targets, new treatments were administered that resulted in patients experiencing significant periods of time when there was no progression of their cancer.
"This clinical trial was unique because patients acted as their own control,'' said Dr. Von Hoff. "We compared each patient's progression-free survival, following treatment based on molecular profiling, to how their tumors progressed under their prior treatment regimens, before molecular profiling."
In a significant number of patients, the targeted treatments provided significantly longer periods when tumors did not progress, or even shrunk, said Dr. Von Hoff, who also is a Medical Director of US Oncology and a former Director of the Arizona Cancer Center at the University of Arizona.
Dr. Von Hoff said the new study was done in a way that avoided issues surrounding tumor subtypes and differences in individual biology, which have confounded other clinical trials.
He said this clinical trial demonstrated the value of personalized medicine, in which treatments are prescribed based on an individual's specific genetic makeup. The type of drugs, dosages, their delivery and other treatment aspects -- all are based on each patient's individual medical needs.
Among the patients, 27 percent had breast cancer, 17 percent had colorectal cancer, 8 percent had ovarian cancer and 48 percent had cancers that were classified as miscellaneous.
Patients experienced varying levels of improvement. Among those with breast cancer, the period of progression-free survival increased for 44 percent of patients; for colorectal, 36 percent of patients; for ovarian, 20 percent of patients; and for miscellaneous cancers the improvement was seen in 16 percent of patients.
"With this trial, we are showing the power of personalized medicine using the tools we already have available to us. As these tools become more precise and more effective, the value of personalized medicine will increase," Dr. Von Hoff said.
The molecular profiling for this research study was performed by Caris Diagnostics (Caris Dx) in Phoenix.
These results are the first in a series of studies in support of Target Now™, a commercially-available oncology testing service offered exclusively by Caris Dx. Target Now uses cutting-edge molecular profiling techniques, including both DNA microarray and immunohistochemical (IHC) analysis, to provide individualized information about a patient's tumor as an aid to the treating oncologist.
"This trial is evidence of an important breakthrough in the treatment of cancer. We are excited to work with Dr. Von Hoff and TGen as we make this important molecular diagnostic information available to physicians to aid in therapy-selection decision making,'' said David D. Halbert, Chairman and CEO of Caris Diagnostics. "The valuable information provided through the Target Now panel of tests improves patient care while reducing costs for the payer.''
Clinical studies were conducted by TCRS at the Virginia G. Piper Cancer Center at Scottsdale Healthcare Shea Medical Center. Scottsdale Healthcare is a primary clinical research site for TGen.
"Patients in our community have access to ground-breaking, world-class research right in their own backyard thanks to this collaboration," said Tom Sadvary, president and CEO of Scottsdale Healthcare. "Our goal is reducing the time it takes to get new treatment discoveries from the research lab to the patient. We are thrilled to see these advances in personalized medicine taking place right here in Scottsdale."
The recent clinical study was dubbed the Bisgrove Trial, after longtime Scottsdale Healthcare supporter Jerry Bisgrove. The trial was funded through a $5 million grant from Mr. Bisgrove's Stardust Foundation to the Scottsdale Healthcare Foundation. Mr. Bisgrove has been a patient at Scottsdale Healthcare and is a member of the Scottsdale Healthcare Foundation Board of Trustees. In honor of the Stardust gift, the research building at the Virginia G. Piper Cancer Center at Scottsdale Healthcare Shea Medical Center is named the Debi and Jerry Bisgrove Research Pavilion.
"The Stardust Foundation is proud to have played a key role in the advancements in cancer research represented by Dr. Von Hoff's clinical trial. We believe we are closer than ever to finding a cure for this devastating disease that affects so many millions,'' Mr. Bisgrove said.
The Translational Genomics Research Institute
The study included 66 patients at nine centers across the United States, including Scottsdale Heathcare. Dr. Von Hoff also is the Chief Scientific Officer of TGen Clinical Research Services (TCRS) at Scottsdale Healthcare, a partnership between TGen and Scottsdale Healthcare that is administered by the Scottsdale Clinical Research Institute (SCRI) at Scottsdale Healthcare.
All of the patients had previously experienced growth of their tumors while undergoing as many as two to six prior cancer treatments, including conventional chemotherapy.
However, after molecular profiling identified precise targets, new treatments were administered that resulted in patients experiencing significant periods of time when there was no progression of their cancer.
"This clinical trial was unique because patients acted as their own control,'' said Dr. Von Hoff. "We compared each patient's progression-free survival, following treatment based on molecular profiling, to how their tumors progressed under their prior treatment regimens, before molecular profiling."
In a significant number of patients, the targeted treatments provided significantly longer periods when tumors did not progress, or even shrunk, said Dr. Von Hoff, who also is a Medical Director of US Oncology and a former Director of the Arizona Cancer Center at the University of Arizona.
Dr. Von Hoff said the new study was done in a way that avoided issues surrounding tumor subtypes and differences in individual biology, which have confounded other clinical trials.
He said this clinical trial demonstrated the value of personalized medicine, in which treatments are prescribed based on an individual's specific genetic makeup. The type of drugs, dosages, their delivery and other treatment aspects -- all are based on each patient's individual medical needs.
Among the patients, 27 percent had breast cancer, 17 percent had colorectal cancer, 8 percent had ovarian cancer and 48 percent had cancers that were classified as miscellaneous.
Patients experienced varying levels of improvement. Among those with breast cancer, the period of progression-free survival increased for 44 percent of patients; for colorectal, 36 percent of patients; for ovarian, 20 percent of patients; and for miscellaneous cancers the improvement was seen in 16 percent of patients.
"With this trial, we are showing the power of personalized medicine using the tools we already have available to us. As these tools become more precise and more effective, the value of personalized medicine will increase," Dr. Von Hoff said.
The molecular profiling for this research study was performed by Caris Diagnostics (Caris Dx) in Phoenix.
These results are the first in a series of studies in support of Target Now™, a commercially-available oncology testing service offered exclusively by Caris Dx. Target Now uses cutting-edge molecular profiling techniques, including both DNA microarray and immunohistochemical (IHC) analysis, to provide individualized information about a patient's tumor as an aid to the treating oncologist.
"This trial is evidence of an important breakthrough in the treatment of cancer. We are excited to work with Dr. Von Hoff and TGen as we make this important molecular diagnostic information available to physicians to aid in therapy-selection decision making,'' said David D. Halbert, Chairman and CEO of Caris Diagnostics. "The valuable information provided through the Target Now panel of tests improves patient care while reducing costs for the payer.''
Clinical studies were conducted by TCRS at the Virginia G. Piper Cancer Center at Scottsdale Healthcare Shea Medical Center. Scottsdale Healthcare is a primary clinical research site for TGen.
"Patients in our community have access to ground-breaking, world-class research right in their own backyard thanks to this collaboration," said Tom Sadvary, president and CEO of Scottsdale Healthcare. "Our goal is reducing the time it takes to get new treatment discoveries from the research lab to the patient. We are thrilled to see these advances in personalized medicine taking place right here in Scottsdale."
The recent clinical study was dubbed the Bisgrove Trial, after longtime Scottsdale Healthcare supporter Jerry Bisgrove. The trial was funded through a $5 million grant from Mr. Bisgrove's Stardust Foundation to the Scottsdale Healthcare Foundation. Mr. Bisgrove has been a patient at Scottsdale Healthcare and is a member of the Scottsdale Healthcare Foundation Board of Trustees. In honor of the Stardust gift, the research building at the Virginia G. Piper Cancer Center at Scottsdale Healthcare Shea Medical Center is named the Debi and Jerry Bisgrove Research Pavilion.
"The Stardust Foundation is proud to have played a key role in the advancements in cancer research represented by Dr. Von Hoff's clinical trial. We believe we are closer than ever to finding a cure for this devastating disease that affects so many millions,'' Mr. Bisgrove said.
The Translational Genomics Research Institute
Healthcare Current Events and Healthcare News RSSPreventing H1N1 spread to health care workers: Dilemma, debate and confusion
A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers.
Full recovery now possible for an 'untreatable' mental illness
Patients coping with the chaos and misery of Borderline Personality Disorder now have reason for strong confidence in making major life changes through a new treatment, Schema Therapy.
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
Pushing the brain to find new pathways
Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities.
Your Own Stem Cells Can Treat Heart Disease
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells.
Neuroimaging provides insights into new treatment options for Alzheimer's disease
With about 35 million people around the world suffering from Alzheimer's disease (AD) by the year 2010 and an expectation that these numbers will double every twenty years with approximately 115 million cases by 2050, pressure on healthcare systems worldwide will be intense.
'Emotions increase or decrease pain': researchers
Getting a flu shot this fall? Canadians scientists have found that focusing on a pretty image could alleviate the sting of that vaccine.
90 percent of Africans are not protected by smoke-free laws
As African nations are poised to undergo the highest increase in the rate of tobacco use among developing countries, nearly 90 percent of people on the continent remain without meaningful protection from secondhand smoke, according to a new report released at a regional cancer conference today.
Study examines quality and duration of primary care visits
Adult primary care visits have increased in quality, duration and frequency between 1997 and 2005, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Higher carotid arterial stenting rates associated with poorer clinical outcomes
Among eligible Medicare beneficiaries, increased use of carotid arterial stenting (CAS) procedures to treat carotid stenosis-the narrowing of the carotid artery-is associated with higher rates of mortality and adverse clinical outcomes, including heart attack and stroke, according to researchers from the University of Pennsylvania School of Medicine.
More Healthcare Current Events and Healthcare News Articles
 |
Healthcare, Guaranteed: A Simple, Secure Solution for America by Ezekiel J. Emanuel (Author), Victor Fuchs (Foreword) America spends more than any other developed nation on healthcare—$2.1 trillion in 2007 alone. But 47 million Americans remain uninsured, and of those Americans who are insured, many suffer from poor health. In his ground-breaking proposal, Dr. Ezekiel Emanuel offers up a plan to comprehensively restructure the delivery and quality of our healthcare. By eliminating employer-healthcare and establishing an independent program to evaluate healthcare plans and insurance companies, he offers a no-nonsense guide to how government can institute private insurance options that will allow each of us a choice of doctor and plan. With the rate of healthcare costs rapidly outpacing our gross domestic product, we can no longer afford to maintain our fragmented delivery of care, or entertain... |
 |
Understanding Healthcare by Richard Saul Wurman (Author) Understanding your automobile and how to service and repair it is certainly useful. Understanding your body and how to maintain and improve it is far more important. Understanding Healthcare answers 100s of key questions and contains links to the best websites and other resources. Understanding Healthcare is a visual encyclopedia -- each spread making the complex clear. Understanding Healthcare takes the powerful tools of information architecture to create a roadmap for each reader. Understanding Healthcare empowers each of us to constructively navigate through our own patterns of health information as well as those for whom we care. |
 |
The Business of Healthcare Innovation by Lawton Robert Burns (Editor) Robert Lawton Burns focuses on the key role of the 'producers' as the main source of innovation in this wide-ranging analysis of business trends in the manufacturing branch of the health care industry. Written by industry academics and executives, the book provides a detailed overview of the pharmaceutical, biotechnology, genomics/proteomics, medical device and information technology sectors. Most importantly, it describes the growing convergence between these sectors and the need for executives in one sector to increasingly draw upon trends in the others. |
 |
The Plan: Barack Obama's Promise to America and His Plan for the Economy, Iraq, Healthcare, and More by Barack Obama (Introduction) This book explains in detail President Obama's plan for America's most pressing problems. It describes how Obama intends to re-position the United States as a leader and role model for the world. In the midst of one of the greatest challenges our country has faced, Obama lays out his vision and goals for putting America back on track. Among the topics are: |
 |
Who Killed Health Care?: America's $2 Trillion Medical Problem - and the Consumer-Driven Cure by Regina Herzlinger (Author) In the battle for U.S. health care, patients and doctors are losing. Who Killed Health Care? shows how to win the war. One of the nation's most respected health care analysts, Regina Herzlinger exposes the motives and methods of those who have crippled America's health care system-figures in the insurance, hospital, employment, governmental, and academic sectors. She proves how our current system, which is organized around payers and providers rather than the needs of its users, is dangerously eroding patient welfare and is pushing costs out of the reach of millions. Who Killed Health Care? then outlines Herzlinger's bold new plan for a consumer-driven system that will deliver affordable, high-quality care to everyone. By putting insurance money in... |
 |
An Introduction to the U.S. Health Care System by Steven Jonas (Editor), Raymond Goldsteen (Editor), Karen Goldsteen (Editor) "Dr. Jonas has been a voice in the wilderness preaching sense about both health and health services for years. He clearly identifies the problems and issues facing the system and its beneficiaries, based upon the evidence he has carefully marshaled for the reader...and he challenges the reader to make sense out of the facts, understanding the evidence within a historical and international context, and come up with judgments on needed changes and how to go about making them, starting with the facts which he so generously provides you."--From the Foreword by Anthony R. Kovner, PhD Professor of Health Policy and Management New York University This bestselling text is a concise and balanced classic presenting the domestic health care system. It explains the five... |
|
The Healing of America: A Global Quest for Better, Cheaper, and Fairer Health Care (Thorndike Press Large Print Nonfiction Series) by T. R. Reid (Author) Bestselling author T. R. Reid guides a whirlwind tour of successful health care systems worldwide, revealing possible paths toward U.S. reform. In The Healing of America, New York Times bestselling author T. R. Reid shows how all the other industrialized democracies have achieved something the United States can't seem to do: provide health care for everybody at a reasonable cost. In his global quest to find a possible prescription, Reid visits wealthy, free market, industrialized democracies like our own-including France, Germany, Japan, the U.K., and Canada-where he finds inspiration in example. Reid shares evidence from doctors, government officials, health care experts, and patients the world over, finding that foreign health care systems give everybody quality care at... | |
 |
Critical: What We Can Do About the Health-Care Crisis by Tom Daschle (Author), Jeanne M. Lambrew (Narrator), Scott S. Greenberger (Narrator) A much-needed and hard-hitting plan, from one of the great Democratic minds of our time, to reform America’s broken health-care system. Undoubtedly, the biggest domestic policy issue in the coming years will be America’s health-care system. Millions of Americans go without medical care because they can’t afford it, and many others are mired in debt because they can’t pay their medical bills. It’s hard to think of another public policy problem that has lingered unaddressed for so long. Why have we failed to solve a problem that is such a high priority for so many citizens? Former Senate Majority Leader Tom Daschle believes the problem is rooted in the complexity of the health-care issue and the power of the interest groups—doctors, hospitals,... |
 |
Safety 1st Detach And Go Grooming And Healthcare Kit by Safety 1st detaches for convenience! |
 |
Frontline: Sick Around the World Four in five Americans say the healthcare system needs fundamental change. Can the U.S. learn anything from the rest of the world about how to run a healthcare system, or are these nations so culturally different that their solutions would not be acceptable? FRONTLINE correspondent T.R. Reid examines the healthcare systems of other advanced capitalist democracies to see what ideas might help the U.S. reform its broken healthcare system. |
| © 2009 BrightSurf.com |